The evidence to date suggests that this is mediated via altered insulin secretion [26], [27] although this was not confirmed in the most recent type 2 diabetes GWAS where the postulated mechanism of action for KCNQ1 was designated unclassified [1]. The gene discussed is INS; the disease is type 2 diabetes mellitus.